medigraphic.com

2012, Number 6

<< Back

Cir Cir 2012; 80 (6)

Brain death, physiopathology, optimal care and hormonal therapy for cardiac donation

Zetina-Tun H, Lezama-Urtecho C, Urías-Báez R, Careaga-Reyna G

Language: Spanish
References: 28
Page: 573-577
PDF size: 150.80 Kb.


ABSTRACT

Heart transplantation goes on leading the standard therapeutic for the terminal heart failure. The success of this procedure and the post-transplantation survival, meaning during the perioperative time, is depending because of the good performance of the donor graft, due to this situation, the pre-harvesting evaluation is very important. The brain death brought many changes: 1) first of all the “adrenergic storm” with its hemodynamic and cardiac dangerous events; 2) Thyroidal hormones, cortisol, vasopressin, and seric insulin depletion with its metabolic consequences respectively.
Since 2002 during the Crystal Consensus started the using of the hormonal therapeutic hormones with triyodothironine, vasopressin and metilprednisolone for improving, meaning those limitrophes ones, the performance donor hearts with brain death, and the goal has been to harvest more donated organs en quality and numbers. This hormonal therapeutic has had great acceptation and successful; having more harvesting of solids organs: hearts, lungs and kidneys; with more performance and surviving at 1 year post-transplantation and less mortality. Our Hospital began the hormonal therapeutic since January 2011with excellent results. On this basis we can concluded that, hormonal rescue therapy, improves the availability and performance of organs for transplantation.


REFERENCES

  1. Keegan MT, Wood KE, Coursin DB. An Update on ICU Management of the potential organ donor. Yearbook of Intensive Care and Emergency Medicine. Springer-Verlag Berlin Heidelberg 2010 p. 547.

  2. Stoica SC, Satchithananda DK, White PA, Sharples L, Parameshwar J, Redington AN, et al. Brain death leads to abnormal contractile properties of the human donor right ventricle. J Thorac Cardiovasc Surg 2006;132(1):116-123.

  3. Novitzky D. Detrimental effects of brain deaths on the potential organ donor. Transplant Proc 1997;29(8):3770-3772.

  4. Berman M, Ali A, Ashley E, Freed D, Clarke K, Tsui S, et al. Is stress cardiomiopathy the underlaying cause of ventricular dysfunction associated with brain death? J Heart Lung Transplant 2010;29:957-965.

  5. Bhatia SJ, Kirshenbaun JM, Shemin RJ, Cohn LH, Collins JJ, Di Sesa VJ, et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation 1987;76:819-826.

  6. Stoica SC, Satchithananda DK, White PA, Parameshwar J, Redington AN, Large SR. Noradrenaline Use in the Human Donor and Relationship with Load-Independent Right Ventricular Contractility. Transplantation 2004;78(8):1193-1197.

  7. Kolin A, Norris JW. Myocardial damage from acute cerebral lesions. Stroke 1984;15:990-993.

  8. Novitzky D, Cooper DKC, Rosendale JD, Kauffman HM. Hormonal Therapy of the Brain-Dead Organ Donor: Experimental and Clinical Studies. Transplantation 2006;82(11):1396-1401.

  9. Greenhoot JH, Reichenbach DD. Cardiac injury and subarachnoid hemorrhage: A clinical, pathological, and physiological correlation. J Neurosurg 1969;30(5):521-531.

  10. Kunzendorf U, Hohenstein B, Oberbarnscheid M, Müller E, Renders L, Schott GE, et al. Duration of Donor Brain Death and its Influence on Kidney Graft Function. Am J Transplant 2002;2(3):292-294.

  11. Nijboer WN, Schuurs TA, van der Hoeven JAB, Leuvenink HGD, Homan van der Heide JJ, van Goor H, et al. Effects of brain death on stress and inflammatory response in the human donor kidney. Transplant Proc 2005;37(1):367-369.

  12. Novitzky D, Wicomb WN, Cooper DKC, Rose AG, Reichart B. Prevention of Myocardial Injury During Brain Deaths by Total Cardiac Sympathectomy in the Chacma Baboon. Ann Thorac Surg 1986:41(5):520-524.

  13. Guner M, Pirat A, Zeyneloglu P, Karaaslan P, Sevmis S, Colak T, et al. Effect of the Interval Between Organ Donor Brain Death and Organ Harvesting on Kidney Graft Function After Transplantation. Transplant Proc 2007;39(4):837-841.

  14. Wicomb WN, Cooper DK, Lanza RP, Novitzky D, Isaacs S. The effects of brain death and 24 hours` storage by hypothermic perfusion on donor heart function in the pig. J Thorac Cardiovasc Surg 1986;91(6):896-909.

  15. Novitzky D, Cooper DK, Morrell D, Issacs S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 1988;45(1):32-36.

  16. Pratschke J, Wilhelm MJ, Kusaka M, Beato F, Milford EL, Hancock WW, et al. Accelerated Rejection of Renal Allografts From Brain- Dead Donors. Ann Surg 2000;232(2):263-271.

  17. Birks EJ, Burton PBJ, Owen V, Mullen AJ, Hunt D, Banner NR, et al. Elevated Tumor Necrosis Factor-α and Interleukin-6 in Myocardium and Serum of Malfunctioning Donor Hearts. Circulation 2000;102:III352-III358.

  18. Pratschke J, Kofla G, Wilhelm MJ, Vergopoulos A, Laskowski I, Shaw GD, et al. Improvements in Early Behavior of Rat Kidney Allografts After Treatment of the Brain-Dead Donor. Ann Surg 2001;234(6):732-740.

  19. Zaroff JG, Rosengard BR, Armstrong WF, Babcock WD, D’Alessandro A, Dec GW, et al. Maximizing use of organs recovered from the cadaver donor: cardiac recommendations. J Heart Lung Transplant 2002;21(11):1153-1160.

  20. Constanzo RM, Dipchand A, Starling R, Anderson A, Chan M, Desai S, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant 2010;29(8):914-956.

  21. Wheeldon DR, Potter CD, Oduro A, Wallwork J, Large SR. Transforming the “unacceptable” donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995;14(4):734-742.

  22. Rosendale JD, Kauffmann HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER, et al. Aggressive pharmacologic donor management results in more transplanted organs1. Transplantation 2003;75(4):482-487.

  23. Argüero-Sánchez R, Careaga-Reyna G, Castaño-Guerra R. Capìtulo 6, Donadores. En: Argüero R, Castaño R, Careaga G. Trasplante de corazón, pulmón y corazón-pulmón. Ed. Masson-Salvat, México, 1995 p. 32-42.

  24. Wheeldon DR, Potter CD, Jonas M, Wallwork J, Large SR. Using “unsuitable” hearts for transplantation. Eur J Cardiothorac Surg 1994;8(1):7-9.

  25. Careaga-Reyna G, Zetina-Tun HJ, Lezama-Urtecho CA. Programa de trasplante cardiaco de la Unidad Médica de Alta Especialidad, Hospital General Dr. Gaudencio González Garza, del Centro Médico Nacional “La Raza”. Rev Invest Clin 2011;63(Supl 1):85-90.

  26. Careaga-Reyna G, Ramírez-Castañeda S, Ramírez-Castañeda A. Importancia de la evaluación terciaria del potencial donador en trasplante de corazón. Rev Mex Cardiol 2008;19(3):149-151.

  27. Nah D, Basha H, Liu M, Moazami N, Ewald G. Increased recovery of thoracic organs after hormonal resuscitation therapy. J Heart Lung Transplant 2010;29:594-596.

  28. Abdelnour T, Rieke S. Relationship of Hormonal Resuscitation The-rapy and Central Venous Pressure on Increasing Organs for Transplant. J Heart Lung Transplant 2009;28(5):480-485.




2020     |     www.medigraphic.com